Export 4 results:
Author Title Type [ Year(Desc)]
Filters: Author is Ravi, Nithin Sam  [Clear All Filters]
2022
George A, Ravi NSam, Prasad K, Panigrahi L, Koikkara S, Rajendiran V, Devaraju N, Paul J, Pai AAnand, Nakamura Y, Kurita R, Balasubramanian P, Thangavel S, Marepally S, Velayudhan SR, Srivastava A, Mohankumar KM.  2022.  Efficient and error-free correction of sickle mutation in human erythroid cells using prime editor-2.. Front Genome Ed. 4:1085111. DOI:10.3389/fgeed.2022.1085111.
Devaraju N, Rajendiran V, Ravi NSam, Mohankumar KM.  2022.  Genome Engineering of Hematopoietic Stem Cells Using CRISPR/Cas9 System.. Methods Mol Biol. 2429:307-331. DOI:10.1007/978-1-0716-1979-7_20.
Ravi NSam, Wienert B, Wyman SK, Bell HWilliam, George A, Mahalingam G, Vu JT, Prasad K, Bandlamudi BPrasad, Devaraju N, Rajendiran V, Syedbasha N, Pai AAnand, Nakamura Y, Kurita R, Narayanasamy M, Balasubramanian P, Thangavel S, Marepally S, Velayudhan SR et al..  2022.  Identification of novel HPFH-like mutations by CRISPR base editing that elevate the expression of fetal hemoglobin.. Elife. 11 DOI:10.7554/eLife.65421.
Christopher ACrystal, Venkatesan V, Karuppusamy KV, Srinivasan S, Babu P, Azhagiri MKumar K, Chambayil K, Bagchi A, Rajendiran V, Ravi NSam, Kumar S, Marepally SKumar, Mohankumar KMurugesan, Srivastava A, Velayudhan SR, Thangavel S.  2022.  Preferential Expansion of Human CD34CD133CD90 Hematopoietic Stem Cells Enhances Gene-Modified Cell Frequency for Gene Therapy.. Hum Gene Ther. 33(3-4):188-201. DOI:10.1089/hum.2021.089.